Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
University Hospital of North Norway, Tromsø, Troms, Norway
St. Antonius Hospital, Nieuwegein, Netherlands
Aleris-Hamlet Hospital, Frederiksberg, Denmark
Mayo Clinic in Arizona, Phoenix, Arizona, United States
The Children's Hospital, Aurora, Colorado, United States
Piracicaba Dental School, Piracicaba, São Paulo, Brazil
St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada
Consorci Sanitari de Terrassa, Terrassa, Barcelona, Spain
Nationwide Children's Hospital, Columbus, Ohio, United States
Bispebjerg Hospital, Copenhagen, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.